Stem Cell Biology and Regenerative Medicine

Funding

FundingIn addition to its generous endowment, the Institute for Stem Cell Biology and Regenerative Medicine at Einstein is supported by external sources, including the NIH and the New York State Empire State Stem Cell (NYSTEM) Board. Created in 2007, NYSTEM provided substantial funding support for stem cell research over the next decade. Notably, Einstein is among the highest-ranked institutions in New York competing for state support and, to date, has received more stem cell funding from NYSTEM than any other institution.

Funding from NYSTEM supports the creation of the Einstein Comprehensive Pluripotent Stem Cell Center, which consists of three units: the Human Pluripotent Stem Cell Unit, the Cell-Sorting and Xenotransplantation Unit, and the Stem Cell Genomic Unit.

In addition, Einstein and its University Hospital, Montefiore Medical Center, have established consortia for blood cell disease and liver transplantation in New York State. The consortia aim to link research institutions and corporations, build and strengthen interdisciplinary research teams, establish core research facilities, and develop stem cell training and education programs. A not for- profit institution, Montefiore is one of the nation’s largest hospitals, with 1,491 beds.

Einstein Benefactors

The endowment for the Institute comes in large part from longtime Einstein benefactors Ruth L. and David S. Gottesman.

Prior to joining the Einstein Board of Overseers in 2002, Dr. Ruth Gottesman had a distinguished 33-year academic career at the medical school. In 1968, she joined Einstein’s Children’s Evaluation and Rehabilitation Center (CERC) to develop a program for children with dyslexia and other learning disabilities. She went on to serve as CERC’s director of psychoeducational services and later as director of the adult literacy program. In 1999, she became founding director of the Fisher Landau Center for the Treatment of Learning Disabilities, a new division of CERC that was established to provide interdisciplinary services to individuals of all ages with learning disabilities.

David Gottesman is the founder and senior managing director of the First Manhattan Company, an investment advisory firm. He was chairman of the Board of Yeshiva University from 1990 to 1998.


 

 
Click here to log in